期刊文献+

超声监测胸外科肿瘤术后低分子肝素预防深静脉血栓效果的观察 被引量:4

Color Doppler ultrasonography in monitoring thrombosis of lower limb deep vein after malignantthoracic tumor surgery
原文传递
导出
摘要 对30例胸外科恶性肿瘤手术患者于术后24h开始每12小时腹壁皮下注射低分子肝素0.3ml,连续3d,行超声检查观察深静脉血栓形成(DVT)情况(研究组),并以30例未应用肝素者为对照。术后检出DVT7例,其中研究组1例(3%),发生率显著低于对照组的20%(6例)(P〈0.05),血栓最早于术后1d检出,单纯小腿肌间静脉血栓6例,胫后静脉血栓1例。与对照组比较,研究组术后1d时纤维蛋白原(FIB)、D-二聚体无显著变化(P〉0.05),术后3d时FIB、D-二聚体显著降低(P〈0.05)。低分子肝素显著降低术后高凝状态,减少下肢DVT发生;超声可作为术后早期监测无痒状小腿DVT及预防措旆效果的首诜方法。 Sixty patients underwent surgery for malignant thoracic tumor were evenly randomized into control group (group A) and treatment group (group B). 0. 3 ml low-molecular-weight heparin was injected per 12 h for 3 d in group B from 24 h after surgery. Bilateral venous sonography of lower extremities were performed before and dl, d3 after operation. Blood coagulation marks PLT, PT, APTT, Fibrinogen (FIB) and D-dimer were determined at the same time. Diagnosis of calf vein thrombosis after surgery was confirmed by color Doppler sonography in 7 patients: 1 in group B(3%) and 6 in group A(20%) (P〈0.05). Thrombosis at calf intermuscular vein was found in 6 patients and thrombosis at posterior tibial vein in 1 patient. FIB and D-dimer had no significant difference on the dl ( P 〉 0. 05 ) between two groups, butsignificantly lower on the d3 after surge group B than that ill group A ( P 〈 O. 05 ). eight heparin reduced blood hypereoagulation state and thromlosis. Color Doppler sonography can be a va]uable method deteeting asymplomatit deep vein thrombosis in the early stage after surgery and monitoring the efficacy of thrombosis prevention.
出处 《中华全科医师杂志》 2012年第3期231-233,共3页 Chinese Journal of General Practitioners
关键词 超声检查 静脉血栓形成 Uhrasonography genous thrombosis
  • 相关文献

参考文献6

二级参考文献18

  • 1陈晓云,吴新民.硬膜外阻滞对胸科手术患者血液流变学及凝血功能的影响[J].中华麻醉学杂志,2004,24(6):410-414. 被引量:47
  • 2袁训芝,吴新民,陈铭,袁家颖,张生锁.开胸患者术后深静脉血栓形成与血液凝血活性的变化[J].北京大学学报(医学版),2004,36(5):529-532. 被引量:15
  • 3李辉,侯生才.胸外科术后肺栓塞——并不少见的并发症[J].中华胸心血管外科杂志,2005,21(2):126-128. 被引量:18
  • 4Kilic D, Akin S, Findikcioglu A, et al. Low-molecular-weight heparin for treatment of submassive pulmonary embolism after pneumonectomy. Gen Thorac Cardiovasc Surg,2007,55:287- 289.
  • 5Meissner MH, Wakefield TW, Ascher E, et al. Acute venous disease: venous thrombosis and venous trauma. J Vase Surg, 2007,46 (Suppl): 25S - 53S.
  • 6Goad KE, Gralnick HR. Coagulation disorders in cancer. Hematol Oncol CAin North Am, 1996,10:457 - 484.
  • 7Nicolaides A, Goldhaber SZ, Maxwell GL, et al. Cost benefit of intermittent pneumatic compression for venous thromboembolism prophylaxis in general surgery. Int Angiol, 2008,27:500 - 506.
  • 8Nutescu EA. Assessing, preventing, and treating venous thromboembolism: evidence-based approaches. Am J Health Syst ann,2009,64( 11 Suppl 7) :S5 - 13.
  • 9Wells PS. Integrated strategies for the diagnosis of venous thromboembolism. J Thromb Haemost,2007,5(Suppl 1) :41 - 50.
  • 10Leizorovicz A, Cohen AT, Turpie AGG, et al. Randomized ,placebo controlled trial of dafleparin for the prevention of venous t hromboembolism in acutely Ⅲ medical patient s. Cirodation,2004,110:874 - 879.

共引文献287

同被引文献23

  • 1刘艳梅,翟振国,王辰.肺血栓栓塞症-深静脉血栓形成的分子流行病学[J].国外医学(呼吸系统分册),2004,24(5):346-348. 被引量:1
  • 2王乐民.围手术期静脉血栓栓塞症的防治[J].中华全科医师杂志,2006,5(5):272-274. 被引量:7
  • 3Walenga JM,Lyman GH. Evolution of heparin anticoagu- lants to ultra-low-molecular weight heparins: a review of pharmacologic and clinical differences and applications in patients with cancer[J]. Crit Rev Oncol Hematol, 2013, 88(1) :1-18.
  • 4Lee AY, Peterson EA. Treatment of cancer-associated thrombosis[J]. Blood,2013,122(14) :2310-2317.
  • 5Lavau-Denes S, Lacroix P,Maubon A, et al. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study [J]. Cancer Chemother Pharmacol, 2 013,7 2 (1) : 6 5-7 3.
  • 6Hull RD, Townshend G. Long-term treatment of deep- vein thrombosis with low molecular weight heparin: an update of the evidence[J]. Thromb Haemost, 2013,110 (1):14-22.
  • 7Heller S, Krause M. Low molecular weight heparin de- creases thrombosis risk in patients receiving chemothera- py for cancer[J]. Strahlenther Onkol, 2018,189 (6) : 514- 515.
  • 8Eley KA, Parker RJ, Watt-Smith SR. Low molecular weight heparin in patients undergoing free tissue trans- fer following head and neck ablative surgery: review of efficacy and associated complications[J]. Br J Oral Max- illofac Surg, 2013,51 (7) :610-614.
  • 9高飞,李定刚,陶连元,徐青.低分子肝素在中老年人腹部肿瘤围手术期的应用研究[J].中华临床医师杂志(电子版),2012,6(14):3891-3894. 被引量:3
  • 10急性肺血栓栓塞症诊断治疗中国专家共识[J].中华内科杂志,2010,49(1):74-81. 被引量:401

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部